Aswin Menke

2.2k total citations · 1 hit paper
44 papers, 1.6k citations indexed

About

Aswin Menke is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Aswin Menke has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Epidemiology and 10 papers in Physiology. Recurrent topics in Aswin Menke's work include Liver Disease Diagnosis and Treatment (19 papers), Renal and related cancers (11 papers) and Diet and metabolism studies (6 papers). Aswin Menke is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Renal and related cancers (11 papers) and Diet and metabolism studies (6 papers). Aswin Menke collaborates with scholars based in Netherlands, United Kingdom and United States. Aswin Menke's co-authors include Robert Kleemann, Anita M. van den Hoek, Wen Liang, Louis M. Havekes, J. Lindeman, André Wolterbeek, Reinout Stoop, Ann Driessen, Ger H. Koek and Jan M. Spitsbergen and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Aswin Menke

44 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology

2014 438 citations Wen Liang, Aswin Menke et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aswin Menke Netherlands	22	700	606	300	263	205	44	1.6k
Xuelian Xiong China	22	708 1.0×	646 1.1×	246 0.8×	221 0.8×	207 1.0×	34	1.5k
Sung‐E Choi South Korea	22	694 1.0×	450 0.7×	352 1.2×	247 0.9×	216 1.1×	53	1.6k
Marthe Moldes France	24	1.1k 1.5×	659 1.1×	510 1.7×	388 1.5×	236 1.2×	40	2.1k
Elizabeth P. Newberry United States	23	1.2k 1.7×	702 1.2×	288 1.0×	310 1.2×	204 1.0×	45	2.1k
Nuria Martínez-López United States	20	1.0k 1.5×	963 1.6×	401 1.3×	100 0.4×	278 1.4×	26	2.1k
Kyoung‐Jin Oh South Korea	24	1.2k 1.7×	464 0.8×	589 2.0×	184 0.7×	137 0.7×	49	2.1k
Birgit Knebel Germany	25	838 1.2×	502 0.8×	445 1.5×	353 1.3×	123 0.6×	84	1.7k
Kim Ravnskjær Denmark	17	1.2k 1.8×	466 0.8×	573 1.9×	271 1.0×	145 0.7×	30	2.1k
Stefan Lehr Germany	25	780 1.1×	271 0.4×	260 0.9×	201 0.8×	160 0.8×	59	1.6k
Ian Sipula United States	18	565 0.8×	814 1.3×	453 1.5×	241 0.9×	85 0.4×	31	1.6k

Countries citing papers authored by Aswin Menke

Since Specialization

Citations

This map shows the geographic impact of Aswin Menke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aswin Menke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aswin Menke more than expected).

Fields of papers citing papers by Aswin Menke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aswin Menke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aswin Menke. The network helps show where Aswin Menke may publish in the future.

Co-authorship network of co-authors of Aswin Menke

This figure shows the co-authorship network connecting the top 25 collaborators of Aswin Menke. A scholar is included among the top collaborators of Aswin Menke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aswin Menke. Aswin Menke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morrison, Martine C., Arianne van Koppen, Eveline Gart, et al.. (2025). Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH ‐Associated Fibrosis. The FASEB Journal. 39(12). e70735–e70735. 1 indexed citations

Caspers, Martien P. M., Nanda Keijzer, Robert Kleemann, et al.. (2024). Translatability of mouse muscle-aging for humans: the role of sex. GeroScience. 46(3). 3341–3360. 7 indexed citations

Attema, Joline, Aswin Menke, Martien P. M. Caspers, et al.. (2024). Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr−/−.Leiden mice. The FASEB Journal. 38(20). e70087–e70087. 3 indexed citations

Gart, Eveline, Wim van Duyvenvoorde, Jessica Snabel, et al.. (2023). Translational characterization of the temporal dynamics of metabolic dysfunctions in liver, adipose tissue and the gut during diet-induced NASH development in Ldlr−/−.Leiden mice. Heliyon. 9(3). e13985–e13985. 8 indexed citations

Stokman, Geurt, Martine C. Morrison, Lars Verschuren, et al.. (2023). Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences. 24(10). 8494–8494. 18 indexed citations

Stokman, Geurt, Elsbet Pieterman, Martine C. Morrison, et al.. (2023). Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation. International Journal of Molecular Sciences. 24(9). 7818–7818. 12 indexed citations

Dubbeld, Jeroen, Bart van Hoek, Aswin Menke, et al.. (2023). Novel Explanted Human Liver Model to Assess Hepatic Extraction, Biliary Excretion and Transporter Function. Clinical Pharmacology & Therapeutics. 114(1). 137–147. 7 indexed citations

Caspers, Martien P. M., Nanda Keijzer, Joline Attema, et al.. (2023). Caloric Restriction Combined with Immobilization as Translational Model for Sarcopenia Expressing Key-Pathways of Human Pathology. Aging and Disease. 14(3). 937–937. 1 indexed citations

Morrison, Martine C., Eveline Gart, Wim van Duyvenvoorde, et al.. (2022). Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr−/−.Leiden Mice. International Journal of Molecular Sciences. 23(4). 2325–2325. 19 indexed citations

10.

Kleemann, Robert, Wim van Duyvenvoorde, Nanda Keijzer, et al.. (2022). Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences. 23(18). 10736–10736. 9 indexed citations

11.

Gart, Eveline, Wim van Duyvenvoorde, Karin Toet, et al.. (2021). Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells. Biomedicines. 9(12). 1954–1954. 33 indexed citations

12.

Pouwer, Marianne, Suvi E. Heinonen, Margareta Behrendt, et al.. (2019). The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis. Journal of Diabetes Research. 2019. 1–13. 9 indexed citations

13.

Morrison, Martine C., Lars Verschuren, Kanita Salic, et al.. (2018). Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice. Hepatology Communications. 2(12). 1513–1532. 53 indexed citations

14.

Liang, Wen, J. Lindeman, Aswin Menke, et al.. (2014). Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1β-induced chronic inflammation. Laboratory Investigation. 94(5). 491–502. 72 indexed citations

15.

Groot, Didima de, et al.. (2014). Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs. Reproductive Toxicology. 49. 101–116. 37 indexed citations

16.

Liang, Wen, Aswin Menke, Ann Driessen, et al.. (2014). Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology. PLoS ONE. 9(12). e115922–e115922. 438 indexed citations breakdown →

17.

Huls, Miriam, Fernando Ulloa‐Montoya, Aernout Luttun, et al.. (2009). Breast cancer resistance protein 1 (bcrp) and p-glycoprotein (mdr1) are key players in renal regeneration after ischemic injury. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(2). 204–204. 1 indexed citations

18.

Dijk, Jeroen P. van, L. T. F. Van De Locht, Aswin Menke, et al.. (2002). Abnormal WT1 expression in the CD34‐negative compartment in myelodysplastic bone marrow. British Journal of Haematology. 118(4). 1027–1033. 28 indexed citations

19.

Guo, Jian-Kan, Aswin Menke, Marie-Claire Gübler, et al.. (2002). WT1 is a key regulator of podocyte function. Human Molecular Genetics. 11(6). 2 indexed citations

20.

Menke, Aswin, et al.. (1998). The Wilms’ tumor suppressor WT1: Approaches to gene function. Kidney International. 53(6). 1512–1518. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact